In 2023, the FDA classified TB-500 as a Category 2 bulk drug substance, which has implications for compounding pharmacies and clinical access
Using the same spot over and over can lead to the buildup of scar tissue (lipohypertrophy), which can impair absorption and make injections more difficult and painful
Sustainable practices, including responsible sourcing of raw materials, eco-friendly packaging, and adherence to regulatory standards, are becoming standard across the sector
While much of this research remains preliminary and should not be interpreted as establishing medical indications for injectable glutathione, these investigations hint at potential future applications that may expand glutathione's clinical relevance
These changes initiate cascading cellular programs that continue independently of the peptides presence, similar to how lighting a fire differs from being the fuel that keeps it burning